Ghent University Academic Bibliography

1 – 8 of 8

show: 10
|
sort: year (new to old)

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://biblio.ugent.be/publication?embed=1&q=author%3D%22Schlierf%2C+S*%22+or+(type+exact+bookEditor+and+editor%3D%22Schlierf%2C+S*%22)&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1&amp;hide_cluster=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

Email this snippet

2010
- C3
- conference
mir-17-92 is a master regulator of TGFβ-pathway activity in neuroblastoma
Pieter Mestdagh UGent, Anna-Karin Böstrom, Francis Impens UGent, Erik Fredlund, Kris Von Stedingk, Bart Ghesquière UGent, Stefanie Schlierf, Johannes Schulte, Alexander Schramm and Kris Gevaert UGent, et al. (2010) Belgian Society of Human Genetics, 10th Annual meeting, Abstracts. Mark
- C3
- conference
Deep sequencing reveals differential expression of microRNAs in favourable versus unfavourable neuroblastoma
Johannes Schulte, Tobias Marshall, Marcel Martin, Philipp Rosenstiel, Pieter Mestdagh UGent, Stefanie Schlierf, Theresa Thor, Jo Vandesompele UGent, Angelika Eggert and Stefan Schreiber, et al. (2010) PEDIATRIC BLOOD & CANCER. 55(5). p.826-827 Mark
- A1
- journalArticle
MYCN/c-MYC-induced microRNAs repress coding gene networks associated with poor outcome in MYCN/c-MYC-activated tumors
Pieter Mestdagh UGent, E Fredlund, Filip Pattyn UGent, JH Schulte, D Muth, Joëlle Vermeulen UGent, Candy Kumps UGent, S Schlierf, Katleen De Preter UGent and Nadine Van Roy UGent, et al. (2010) ONCOGENE. 29(9). p.1394-1404 Mark
- A1
- journalArticle
Accurate prediction of neuroblastoma outcome based on miRNA expression profiles
Johannes H Schulte, Benjamin Schowe, Pieter Mestdagh UGent, Lars Kaderali, Prabhav Kalaghatgi, Stefanie Schlierf, Joëlle Vermeulen UGent, Bent Brockmeyer, Kristian Pajtler and Theresa Thor, et al. (2010) INTERNATIONAL JOURNAL OF CANCER. 127(10). p.2374-2385 Mark
- A1
- journalArticle
Deep sequencing reveals differential expression of microRNAs in favorable versus unfavorable neuroblastoma
Johannes H Schulte, Tobias Marschall, Marcel Martin, Philipp Rosenstiel, Pieter Mestdagh UGent, Stefanie Schlierf, Theresa Thor, Jo Vandesompele UGent, Angelika Eggert and Stefan Schreiber, et al. (2010) NUCLEIC ACIDS RESEARCH. 38(17). p.5919-5928 Mark
- C3
- conference
Accurate prediction of neuroblastoma outcome based on miRNA expression profiles
Johannes Schulte, Benjamin Schowe, Pieter Mestdagh UGent, Lars Kaderali, Prabhav Kalaghatgi, Stefanie Schlierf, Joëlle Vermeulen UGent, Bent Brockmeyer, Kristian Pajtler and Theresa Thor, et al. (2010) PEDIATRIC BLOOD & CANCER. 55(5). p.812-812 Mark
2009
- C3
- conference
Modeling neuroblastomagenesis from neural crest stem cells in vitro and in vivo
J Schulte, A Bohrer, E Mahlow, J Maurer, H Schorle, Katleen De Preter UGent, Jo Vandesompele UGent, Franki Speleman UGent, S Schlierf and K Pajtler, et al. (2009) PEDIATRIC BLOOD & CANCER. 53(5). p.703-704 Mark
- C3
- conference
Prognostic role and functional analyses of miRNA expression in neuroblastoma
S Schlierf, Pieter Mestdagh UGent, T Thor, Katleen De Preter UGent, M Baumann, A Eggert, Jo Vandesompele UGent, A Schramm and JH Schulte (2009) KLINISCHE PADIATRIE. 221(3). Mark